Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
NovoCure Limited (NVCR) had Cost of Goods Sold of $41.11M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$183.58M |
|
$-15.66M |
|
|
Cost of Goods Sold |
$41.11M |
$142.48M |
|
$194.15M |
|
$-10.56M |
|
$-1.89M |
|
$-12.45M |
|
$-12.45M |
|
$-15.66M |
|
$-15.66M |
|
$-15.66M |
|
$-15.66M |
|
$-10.56M |
|
$-8.85M |
|
116.01M |
|
116.01M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$638.52M |
|
$101.95M |
|
$156.67M |
|
$795.19M |
|
$220.71M |
|
$195.89M |
|
$236.39M |
|
$457.10M |
|
$338.09M |
|
$338.09M |
|
$338.09M |
|
116.44M |
|
| Cash Flow Statement Financials | |
$-5.38M |
|
$1.37M |
|
$4.38M |
|
$103.39M |
|
$103.62M |
|
$0.23M |
|
$80.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.89 |
|
-- |
|
-- |
|
0.37 |
|
0.58 |
|
77.61% |
|
-5.75% |
|
-5.75% |
|
-- |
|
-6.78% |
|
-8.53% |
|
$-17.45M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.97 |
|
1.26 |
|
71.49 |
|
-4.63% |
|
-4.63% |
|
-1.97% |
|
-2.93% |
|
$2.90 |
|
$-0.15 |
|
$-0.05 |
|